Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research focused on Testicular cancer and Breast cancer, with related work in Axitinib, Renal cell carcinoma, Kidney cancer. Notable publications include 'Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology', 'Kidney Cancer, Version 3.2015', and 'Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer'.
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216)
Sociodemographic Factors Associated With Rapid Relapse in Triple-Negative Breast Cancer: A Multi-Institution Study
MammaPrint guides treatment decisions in breast Cancer: results of the IMPACt trial
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay
Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
Kidney Cancer, Version 3.2015
Testicular Cancer, Version 2.2015
Abstract S6-03: Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: A New York cancer consortium trial
A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma
Kidney Cancer, Version 2.2014